Cited by 138COVID-19 epidemiological studiesSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies

Seasonal trends in COVID-19 cases, hospitalizations, and mortality in the United States and Europe

Open access
Wiemken, Timothy L., Khan, Farid, Puzniak, Laura, Yang, Wan, Simmering, Jacob, Polgreen, Philip, Nguyen, Jennifer L., Jodar, Luis +1 more·2023·Scientific Reports

Published version of a preprint

Abstract

Determining whether SARS-CoV-2 exhibits seasonality like other respiratory viruses is critical for public health planning. We evaluated whether COVID-19 rates follow a seasonal pattern using time series models. We used time series decomposition to extract the annual seasonal component of COVID-19 case, hospitalization, and mortality rates from March 2020 through December 2022 for the United States and Europe. Models were adjusted for a country-specific stringency index to account for confounding by various interventions. Despite year-round disease activity, we identified seasonal spikes in COVID-19 from approximately November through April for all outcomes and in all countries. Our results support employing annual preventative measures against SARS-CoV-2, such as administering seasonal booster vaccines in a similar timeframe as those in place for influenza. Whether certain high-risk individuals may need more than one COVID-19 vaccine booster dose each year will depend on factors like vaccine durability against severe illness and levels of year-round disease activity.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-023-31057-1

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Seasonal trends in COVID-19 cases are more pronounced in European countries than in countries such as Israel and Qatar, which may affect VE estimates.

    “Another reason to include only European studies is that seasonal trends in COVID-19 cases are more pronounced than in countries such as Israel and Qatar [13, 14], which may also affect the VE estimate.”

    From Effectiveness of COVID-19 vaccines against SARS-CoV-2 infection and severe outcomes in adults: a systematic review and meta-analysis of European studies published up to 22 January 2024 (2025) · cites this paper as [13]

    The Results and Discussion report seasonal spikes in COVID-19 cases in Europe from approximately November through April. The paper does not compare Europe with Israel or Qatar, and its Discussion says the findings are not generalizable beyond the United States and Europe. It discusses vaccine timing, but not whether these seasonal differences affect vaccine-effectiveness estimates. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Wiemken, T. L., Khan, F., Puzniak, L., Yang, W., Simmering, J., Polgreen, P., Nguyen, J. L., Jodar, L., & McLaughlin, J. M.
Affiliations
  • Pfizer (United States) (US)
  • Columbia University (US)
  • University of Iowa (US)
Corresponding author
  • Wiemken, Timothy L.
  • McLaughlin, John M.
Venue
Scientific Reports
Published
2023-03-08
Volume
13
Issue
1
Pages
3886-3886
ISSN
2045-2322 (ISSN-L)
OpenAlex
W4323652706
Cited by
138
References
28
Citations by year
2026: 17 · 2025: 45 · 2024: 62 · 2023: 14
FWCI
29.00
Type
journal article
Language
en
Open access
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • Research Square (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Pfizer
Topics
  • Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
Keywords
COVID-19 pandemic, SARS-CoV-2, seasonal variation, seasonal patterns, COVID-19 cases, hospitalization, mortality, time series decomposition, stringency index, booster vaccination, vaccine durability, respiratory viruses, United States, Europe
MeSH terms
COVID-19, SARS-CoV-2, COVID-19 Vaccines, Europe, Hospitalization, Humans, Immunization, Secondary, Seasons, United States

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review